{"filter":{"health_condition":"liver_disease"},"n_projects":94,"projects":[{"accession":"PRJEB11419","age_categories":{"adolescent":93,"adult":4213,"child":99,"elderly":790,"infant":79,"neonate":1,"unknown":2078},"countries":{"AE":2,"AT":3,"AU":25,"BE":9,"BR":3,"CA":45,"CH":3,"CN":2,"CR":1,"CZ":1,"DE":15,"ES":481,"FM":1,"FR":10,"GB":864,"GE":1,"HK":2,"HR":2,"IE":6,"IT":5,"JE":1,"JP":528,"LV":2,"MD":1,"MN":2,"MX":547,"MY":1,"NL":4,"NO":5,"NZ":1,"PH":86,"PR":1,"RS":3,"SE":1,"TH":6,"US":3501,"ZA":2},"first_public_year":"2015","gbp_per_sample_median":0.12,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":419,"cardiometabolic_other":110,"crohns_disease":7,"gi_infection_or_diarrhoea":26,"healthy_control":241,"ibd_unspecified":46,"ibs":560,"kidney_disease":41,"liver_disease":40,"neurological_psychiatric":379,"other_cancer":218,"other_disease":925,"pregnancy_postpartum":1,"type2_diabetes":91,"ulcerative_colitis":14},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":7353,"papers":[{"doi":"10.1016/j.csbj.2020.08.028","pmcid":"PMC7516180","pmid":"33005310","title":"Multi-population cohort meta-analysis of human intestinal microbiota in early life reveals the existence of infant community state types (ICSTs)."},{"doi":"10.3389/fmolb.2022.949563","pmcid":"PMC9403272","pmid":"36032669","title":"Genomic reconstruction of short-chain fatty acid production by the human gut microbiota."},{"doi":"10.12938/bmfh.2023-043","pmcid":"PMC10767325","pmid":"38188664","title":"Heterogeneity of gut microbiome compositions in the third decade of life in Japanese women: insights from a comparative analysis."},{"doi":"10.1128/msystems.00929-24","pmcid":"PMC11494892","pmid":"39287373","title":"Exploring the vitamin biosynthesis landscape of the human gut microbiota."},{"doi":"10.1128/msystems.00031-18","pmcid":"PMC5954204","pmid":"29795809","title":"American Gut: an Open Platform for Citizen Science Microbiome Research."}],"sample_intervention_arms":{},"sex":{"female":3603,"male":2157},"title":"American Gut Project","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB11419","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB11419_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB11419.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB11419.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB11419.csv.gz"}},{"accession":"PRJEB102033","age_categories":{"unknown":1877},"countries":{"US":1877},"first_public_year":"2025","gbp_per_sample_median":2.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":571,"other_disease":662,"transplant_or_immunocompromised":311},"intervention_design":"observational_with_procedure","intervention_detail":"Mouse gavage with lantibiotic-producing Blautia pseudococcoides SCSK after antibiotic dysbiosis","interventions":["other_intervention"],"n_samples":1877,"papers":[{"doi":"10.1016/j.chom.2025.11.007","pmcid":"PMC12766783","pmid":"41330369","title":"Lantibiotic-producing bacteria impact microbiome resilience and colonization resistance."}],"sample_intervention_arms":{},"sex":{},"title":"Lantibiotic-producing bacteria impact microbiome resilience and colonization resistance","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB102033","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB102033_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB102033.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB102033.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB102033.csv.gz"}},{"accession":"PRJNA850529","age_categories":{"adolescent":61,"adult":829,"elderly":33},"countries":{"PL":923},"first_public_year":"2023","gbp_per_sample_median":2.34,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"allergy_or_atopy":129,"autoimmune_inflammatory":40,"cardiometabolic_other":66,"ibd_unspecified":4,"ibs":21,"kidney_disease":3,"liver_disease":1,"pregnancy_postpartum":6},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":923,"papers":[{"doi":"10.1128/msystems.00986-22","pmcid":"PMC10134842","pmid":"36786595","title":"Host Factors Associated with Gut Mycobiome Structure."},{"doi":"10.1158/2326-6066.cir-23-0592","pmcid":"PMC10985481","pmid":"38315788","title":"Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy."}],"sample_intervention_arms":{},"sex":{"female":438,"male":484},"title":"Host factors associated with gut mycobiome structure","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA850529","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA850529_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA850529.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA850529.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA850529.csv.gz"}},{"accession":"PRJNA912122","age_categories":{"unknown":850},"countries":{"US":850},"first_public_year":"2022","gbp_per_sample_median":2.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":850},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":850,"papers":[{"doi":"10.1038/s41564-023-01560-2","pmcid":"PMC11055453","pmid":"38177297","title":"Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration."},{"doi":"10.1016/j.gastha.2025.100695","pmcid":"PMC12197998","pmid":"40574876","title":"Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease."},{"doi":"10.1371/journal.pone.0337727","pmcid":"PMC12788677","pmid":"41511994","title":"Fecal butyrate and deoxycholic acid quantitation for rapid assessment of the gut microbiome."},{"doi":"10.1038/s41564-023-01493-w","pmcid":"PMC11059310","pmid":"37845315","title":"Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease."}],"sample_intervention_arms":{},"sex":{},"title":"Lactulose-mediated Bifidobacteria expansion promotes a beneficial fecal metabolite profile that is associated with exclusion of antibiotic-resistant pathogens and improved outcomes in advanced liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA912122","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA912122_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA912122.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA912122.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA912122.csv.gz"}},{"accession":"PRJNA1246224","age_categories":{"adult":713},"countries":{"US":713},"first_public_year":"2025","gbp_per_sample_median":3.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":713,"papers":[{"doi":"10.1038/s42255-025-01318-6","pmcid":"PMC12320953","pmid":"40604156","title":"Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease."},{"doi":"10.1038/s41467-026-71981-0","pmcid":"PMC13275893","pmid":"42000726","title":"Multi-kingdom profiling reveals altered gut phage-bacteria-metabolite interactions in MASLD."}],"sample_intervention_arms":{},"sex":{"female":713},"title":"MASLD-A multi-omic study of microbiome and metabolic dysfunction-associated steatotic liver disease (human)","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1246224","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1246224_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1246224.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1246224.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1246224.csv.gz"}},{"accession":"PRJNA1425466","age_categories":{"adult":558},"countries":{"US":558},"first_public_year":"2026","gbp_per_sample_median":1.53,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":278,"liver_disease":280},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":558,"papers":[{"doi":"10.1080/19490976.2026.2655793","pmcid":"PMC13078198","pmid":"41975274","title":"Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease."}],"sample_intervention_arms":{},"sex":{},"title":"Stool metagenome in primary billiary cholangitis (PBC)","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1425466","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1425466_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1425466.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1425466.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1425466.csv.gz"}},{"accession":"PRJNA1425460","age_categories":{"adult":490},"countries":{"US":490},"first_public_year":"2026","gbp_per_sample_median":1.5,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":245,"liver_disease":245},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":490,"papers":[{"doi":"10.1080/19490976.2026.2655793","pmcid":"PMC13078198","pmid":"41975274","title":"Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease."}],"sample_intervention_arms":{},"sex":{},"title":"Stool metagenome in primary sclerosing cholangitis (PSC)","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1425460","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1425460_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1425460.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1425460.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1425460.csv.gz"}},{"accession":"PRJEB76661","age_categories":{"adult":369},"countries":{"DK":350},"first_public_year":"2024","gbp_per_sample_median":8.38,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":350},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":369,"papers":[{"doi":"10.1016/j.jhepr.2026.101848","pmcid":"PMC13233754","pmid":"41935631","title":"Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic analysis of the gut microbiome in patients with alcohol-related liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB76661","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76661_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB76661.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB76661.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76661.csv.gz"}},{"accession":"PRJEB76667","age_categories":{"adult":361},"countries":{"DK":361},"first_public_year":"2024","gbp_per_sample_median":7.31,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Rifaximin-α vs placebo in alcohol-related liver disease, phase 2 trial","interventions":[],"n_samples":361,"papers":[{"doi":"10.1016/j.jhepr.2026.101848","pmcid":"PMC13233754","pmid":"41935631","title":"Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomics of the gut microbiome of individuals treated with rifaximin","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB76667","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76667_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB76667.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB76667.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76667.csv.gz"}},{"accession":"PRJNA1177516","age_categories":{"adult":345},"countries":{"US":345},"first_public_year":"2025","gbp_per_sample_median":7.56,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":30,"other_disease":315},"intervention_design":"single_arm_before_after","intervention_detail":"CFTR modulator elexacaftor/tezacaftor/ivacaftor (ETI), before/1mo/6mo after","interventions":["drug_therapy"],"n_samples":345,"papers":[{"doi":"10.1016/j.jcf.2025.05.006","pmcid":"PMC12393131","pmid":"40483244","title":"Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor/tezacaftor/ivacaftor: Findings from the promise study"}],"sample_intervention_arms":{"drug_therapy":345},"sex":{},"title":"Changes in Fecal Microbiota in Adults with Cystic Fibrosis with 6 Months of CFTR Modulator Therapy Elexacaftor/Tezacaftor/Ivacaftor (ETI)","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1177516","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1177516_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1177516.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1177516.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1177516.csv.gz"}},{"accession":"PRJNA734860","age_categories":{"adult":269,"elderly":72},"countries":{"US":341},"first_public_year":"2023","gbp_per_sample_median":2.83,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":125},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":341,"papers":[{"doi":"10.1002/hep.32197","pmcid":"PMC8930512","pmid":"34633706","title":"Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease."},{"doi":"10.1128/msystems.00033-22","pmcid":"PMC9238400","pmid":"35477306","title":"Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas."},{"doi":"10.1128/msystems.00434-24","pmcid":"PMC11406975","pmid":"39166873","title":"Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes."},{"doi":"10.1080/19490976.2024.2399260","pmcid":"PMC11382720","pmid":"39239875","title":"Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolism."},{"doi":"10.1002/hep4.1490","pmcid":"PMC7109342","pmid":"32258950","title":"Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas"}],"sample_intervention_arms":{},"sex":{"female":238,"male":103},"title":"Stool microbiome of Hispanics in the Cameron County Hispanic Cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA734860","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA734860_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA734860.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA734860.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA734860.csv.gz"}},{"accession":"PRJEB6337","age_categories":{"adult":292,"elderly":20},"countries":{"CN":312},"first_public_year":"2014","gbp_per_sample_median":3.1,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":143,"liver_disease":169},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":312,"papers":[{"doi":"10.1186/s40168-017-0283-5","pmcid":"PMC5501583","pmid":"28683828","title":"VirFinder: a novel k-mer based tool for identifying viral sequences from assembled metagenomic data."},{"doi":"10.3389/fmicb.2018.03166","pmcid":"PMC6315199","pmid":"30631318","title":"Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study."},{"doi":"10.1093/gigascience/giz020","pmcid":"PMC6446249","pmid":"30942867","title":"MGS-Fast: Metagenomic shotgun data fast annotation using microbial gene catalogs."},{"doi":"10.3390/ijms222212431","pmcid":"PMC8625315","pmid":"34830313","title":"Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease"},{"doi":"10.3389/fmicb.2023.1169811","pmcid":"PMC10170289","pmid":"37180228","title":"Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-"}],"sample_intervention_arms":{},"sex":{"female":108,"male":204},"title":"Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB6337","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB6337_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB6337.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB6337.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB6337.csv.gz"}},{"accession":"PRJNA999593","age_categories":{"adult":307},"countries":{"US":307},"first_public_year":"2023","gbp_per_sample_median":3.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":279},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":307,"papers":[{"doi":"10.1097/hep.0000000000000474","pmcid":"PMC10674038","pmid":"37222264","title":"An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations."}],"sample_intervention_arms":{},"sex":{},"title":"An integrated analysis of fecal microbiome and metabolomic features distinguish Non-cirrhotic NASH from healthy control populations","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA999593","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA999593_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA999593.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA999593.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA999593.csv.gz"}},{"accession":"PRJEB89898","age_categories":{"adult":302},"countries":{"HU":302},"first_public_year":"2025","gbp_per_sample_median":2.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":302},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":302,"papers":[{"doi":"10.1016/j.jhepr.2025.101622","pmcid":"PMC12721046","pmid":"41438339","title":"<i>L</i> <i>actococcus A</i> phages predict ACLF while <i>Enterococcus B</i> phages predict bacterial infection in decompensated cirrhosis."}],"sample_intervention_arms":{},"sex":{"female":134,"male":168},"title":"Metagenomic sequences of the fecal microbiome from patients with decompensated cirrhosis and ACLF","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB89898","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB89898_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB89898.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB89898.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB89898.csv.gz"}},{"accession":"PRJEB61882","age_categories":{"adult":278},"countries":{"GB":278},"first_public_year":"2024","gbp_per_sample_median":13.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":278},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT delivered via jejunum vs placebo in advanced cirrhosis patients","interventions":["fmt"],"n_samples":278,"papers":[{"doi":"10.21203/rs.3.rs-3088449/v1","pmcid":null,"pmid":null,"title":"Faecal microbiota transplant restores intestinal barrier function and augments ammonia metabolism in patients with cirrhosis: a randomised single-blind placebo-controlled trial"}],"sample_intervention_arms":{},"sex":{},"title":"PROFIT Trial: FMT in cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB61882","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61882_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB61882.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB61882.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61882.csv.gz"}},{"accession":"PRJDB28938","age_categories":{"unknown":263},"countries":{},"first_public_year":"2026","gbp_per_sample_median":8.86,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":131,"liver_disease":132},"intervention_design":"single_arm_before_after","intervention_detail":"UDCA treatment in treatment-naive PBC patients, samples before and after","interventions":["drug_therapy"],"n_samples":263,"papers":[{"doi":"10.1016/j.medj.2024.08.003","pmcid":null,"pmid":"39305900","title":"Gut microbiome pattern impacts treatment response in primary biliary cholangitis"}],"sample_intervention_arms":{},"sex":{},"title":"Multi-omics reveal host-microbiota interactions in primary biliary cholangitis (PRJCA018532)","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB28938","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB28938_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB28938.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB28938.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB28938.csv.gz"}},{"accession":"PRJNA703757","age_categories":{"unknown":252},"countries":{"CN":252},"first_public_year":"2022","gbp_per_sample_median":6.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_disease":252},"intervention_design":"randomized_controlled_trial","intervention_detail":"Resistant starch supplementation vs placebo, 16 weeks, in NAFLD patients","interventions":["prebiotic_or_fibre"],"n_samples":252,"papers":[{"doi":"10.1016/j.cmet.2023.08.002","pmcid":null,"pmid":"37673036","title":"Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations"},{"doi":"10.1126/scitranslmed.abk0855","pmcid":"PMC9746350","pmid":"35675435","title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development."},{"doi":"10.1186/s40168-023-01604-z","pmcid":"PMC10408196","pmid":"37553697","title":"Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions."},{"doi":"10.1186/s40168-024-01990-y","pmcid":"PMC11730835","pmid":"39810263","title":"Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease."}],"sample_intervention_arms":{"diet_intervention":8,"no_intervention":100,"placebo":50,"prebiotic_or_fibre":49},"sex":{},"title":"Human gut microbiota raw sequence reads from resistant starch intervention project in patients with NAFLD","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA703757","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA703757_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA703757.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA703757.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA703757.csv.gz"}},{"accession":"PRJEB60097","age_categories":{"unknown":240},"countries":{"LV":240},"first_public_year":"2023","gbp_per_sample_median":7.36,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":30,"cardiometabolic_other":30,"colorectal_cancer":59,"healthy_control":59,"liver_disease":31},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":240,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiome in health and disease","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB60097","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB60097_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB60097.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB60097.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB60097.csv.gz"}},{"accession":"PRJNA1039781","age_categories":{"adult":240},"countries":{"US":240},"first_public_year":"2023","gbp_per_sample_median":2.78,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":143,"transplant_or_immunocompromised":97},"intervention_design":"observational_with_procedure","intervention_detail":"Liver transplant recipients, peri-transplant fecal sampling","interventions":["surgery"],"n_samples":240,"papers":[{"doi":"10.1371/journal.pone.0337727","pmcid":"PMC12788677","pmid":"41511994","title":"Fecal butyrate and deoxycholic acid quantitation for rapid assessment of the gut microbiome."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1039781","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1039781_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1039781.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1039781.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1039781.csv.gz"}},{"accession":"PRJNA1372070","age_categories":{"unknown":197},"countries":{"CN":197},"first_public_year":"2026","gbp_per_sample_median":7.24,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":196},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":197,"papers":[{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{},"title":"Hepatocellular Carcinoma Cohort Metagenomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1372070","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372070_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1372070.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1372070.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372070.csv.gz"}},{"accession":"PRJEB52891","age_categories":{"adult":175,"elderly":11},"countries":{},"first_public_year":"2024","gbp_per_sample_median":12.37,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":27,"liver_disease":141,"sepsis_or_infection":14},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":186,"papers":[{"doi":"10.1101/2023.08.06.552152","pmcid":null,"pmid":null,"title":"Pathogenic entero- and salivatypes harbour changes in microbiome virulence and antimicrobial resistance genes with increasing chronic liver disease severity"},{"doi":"10.1038/s41564-025-02223-0","pmcid":"PMC12768972","pmid":"41461922","title":"Microbial collagenase activity is linked to oral-gut translocation in advanced chronic liver disease."},{"doi":"10.1002/imt2.70131","pmcid":"PMC13377410","pmid":"42491347","title":"Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis."}],"sample_intervention_arms":{},"sex":{"female":60,"male":122},"title":"Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB52891","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB52891_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB52891.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB52891.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB52891.csv.gz"}},{"accession":"PRJEB38481","age_categories":{"unknown":185},"countries":{"GB":185},"first_public_year":"2021","gbp_per_sample_median":2.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":185},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":185,"papers":[{"doi":"10.1038/s41522-025-00705-x","pmcid":"PMC12075632","pmid":"40360555","title":"Extensively acquired antimicrobial-resistant bacteria restructure the individual microbial community in post-antibiotic conditions."},{"doi":"10.1002/imt2.70131","pmcid":"PMC13377410","pmid":"42491347","title":"Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis."}],"sample_intervention_arms":{},"sex":{},"title":"Liver Cirrhosis cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB38481","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38481_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB38481.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB38481.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38481.csv.gz"}},{"accession":"PRJNA1398904","age_categories":{"adolescent":2,"adult":147,"child":4,"elderly":31,"infant":1},"countries":{"US":185},"first_public_year":"2026","gbp_per_sample_median":2.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":42,"transplant_or_immunocompromised":143},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":185,"papers":[],"sample_intervention_arms":{},"sex":{"female":78,"male":107},"title":"Enterococcus faecium Driven Metabolic Dysbiosis is Linked to Mortality following Liver Transplant","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1398904","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1398904_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1398904.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1398904.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1398904.csv.gz"}},{"accession":"PRJEB40200","age_categories":{"unknown":182},"countries":{"ES":182},"first_public_year":"2020","gbp_per_sample_median":3.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":181,"other_disease":1},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":182,"papers":[{"doi":"10.1053/j.gastro.2020.08.054","pmcid":null,"pmid":"32941879","title":"Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis."}],"sample_intervention_arms":{},"sex":{},"title":"Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics. Relationship with acute-on-chronic liver failure and mortality and prognosis.","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB40200","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB40200_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB40200.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB40200.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB40200.csv.gz"}},{"accession":"PRJNA1227423","age_categories":{"unknown":176},"countries":{"KR":176},"first_public_year":"2025","gbp_per_sample_median":8.72,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":176},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":176,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic shotgun sequencing data of fecal samples from a liver disease cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1227423","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1227423_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1227423.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1227423.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1227423.csv.gz"}},{"accession":"PRJNA728908","age_categories":{"adult":176},"countries":{"CN":176},"first_public_year":"2022","gbp_per_sample_median":7.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":86},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":176,"papers":[{"doi":"10.1126/scitranslmed.abk0855","pmcid":"PMC9746350","pmid":"35675435","title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development."},{"doi":"10.1186/s40168-024-01990-y","pmcid":"PMC11730835","pmid":"39810263","title":"Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease."},{"doi":"10.1186/s12866-025-04348-y","pmcid":"PMC12522779","pmid":"41087898","title":"Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome."},{"doi":"10.1186/s12967-025-07443-w","pmcid":"PMC12763994","pmid":"41316248","title":"Characterization of the gut virome in patients with nonalcoholic fatty liver disease."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota of baseline individuals in a 4.6-year non-alcoholic fatty liver disease prospective study","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA728908","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA728908_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA728908.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA728908.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA728908.csv.gz"}},{"accession":"PRJEB73985","age_categories":{"adult":175},"countries":{"AT":85,"DE":90},"first_public_year":"2025","gbp_per_sample_median":11.67,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":175},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oat bran β-glucan vs spelt bran fiber vs low-fiber placebo, 12 weeks","interventions":["prebiotic_or_fibre"],"n_samples":175,"papers":[{"doi":"10.1016/j.isci.2025.114019","pmcid":"PMC12721201","pmid":"41438070","title":"Fiber enrichment is not superior to dietary monitoring in MASLD: A dual-center, double-blind, placebo-controlled trial."}],"sample_intervention_arms":{},"sex":{},"title":"Oat beta glucan versus iso dietary fiber or placebo in MASLD: A multicenter, randomized, placebo-controlled dietary study","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB73985","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB73985_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB73985.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB73985.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB73985.csv.gz"}},{"accession":"PRJEB55534","age_categories":{"adult":173},"countries":{"FR":173},"first_public_year":"2023","gbp_per_sample_median":7.22,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":153},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":173,"papers":[{"doi":"10.1002/advs.202517596","pmcid":"PMC13042768","pmid":"41560354","title":"The Gut Commensal Butyricimonas Virosa Modulates Gut Microbiota-Dependent Thiamine Metabolism and Attenuates Mouse Steatotic Liver Disease."},{"doi":"10.1128/msystems.00292-26","pmcid":"PMC13289106","pmid":"42148776","title":"<i>Turicibacter sanguinis</i> is a candidate gut microbial pathobiont that promotes metabolic dysfunction-associated steatohepatitis."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic signatures in the European NAFLD registry metacohort cases","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB55534","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB55534_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB55534.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB55534.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB55534.csv.gz"}},{"accession":"PRJEB89899","age_categories":{"adult":173},"countries":{"AT":4,"BE":7,"DE":36,"DK":16,"ES":21,"FR":1,"GB":3,"IT":58,"NL":9,"PT":1,"SK":17},"first_public_year":"2025","gbp_per_sample_median":6.48,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":173},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":173,"papers":[{"doi":"10.1016/j.jhepr.2025.101622","pmcid":"PMC12721046","pmid":"41438339","title":"<i>L</i> <i>actococcus A</i> phages predict ACLF while <i>Enterococcus B</i> phages predict bacterial infection in decompensated cirrhosis."}],"sample_intervention_arms":{},"sex":{"female":44,"male":129},"title":"Metagenomic sequences of the fecal microbiome from patients with decompensated cirrhosis and ALCF","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB89899","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB89899_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB89899.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB89899.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB89899.csv.gz"}},{"accession":"PRJEB76668","age_categories":{"adult":164},"countries":{"DK":164},"first_public_year":"2024","gbp_per_sample_median":9.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":164},"intervention_design":"randomized_controlled_trial","intervention_detail":"ReFerm postbiotic fermented oats vs Fresubin, 24 weeks","interventions":["dietary_supplement"],"n_samples":164,"papers":[{"doi":"10.1038/s41467-025-60755-9","pmcid":"PMC12214853","pmid":"40595534","title":"The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial."},{"doi":"10.1016/j.jhepr.2026.101848","pmcid":"PMC13233754","pmid":"41935631","title":"Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomics of the gut microbiome of individuals treated with ReFerm","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB76668","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76668_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB76668.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB76668.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76668.csv.gz"}},{"accession":"PRJEB25008","age_categories":{"unknown":159},"countries":{},"first_public_year":"2021","gbp_per_sample_median":3.19,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":159,"papers":[{"doi":"10.3390/metabo12010041","pmcid":"PMC8781791","pmid":"35050163","title":"Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis."},{"doi":"10.1016/j.chom.2025.05.003","pmcid":"PMC12162233","pmid":"40441146","title":"Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease."},{"doi":"10.1186/s12934-022-01973-4","pmcid":"PMC9685977","pmid":"36419034","title":"Machine learning for data integration in human gut microbiome."}],"sample_intervention_arms":{},"sex":{},"title":"The_human_gut_microbiome_in_alcoholic_liver_disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB25008","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB25008_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB25008.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB25008.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB25008.csv.gz"}},{"accession":"PRJNA1092365","age_categories":{"unknown":151},"countries":{"CN":151},"first_public_year":"2025","gbp_per_sample_median":6.48,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":63,"liver_disease":23},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":151,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Raw data used for stduying interaction between bile acid and gut microbiome","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1092365","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1092365_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1092365.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1092365.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1092365.csv.gz"}},{"accession":"PRJNA1422633","age_categories":{"unknown":149},"countries":{"KR":149},"first_public_year":"2026","gbp_per_sample_median":7.81,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":149,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Interpretable machine learning reveals pathoadaptive strain-level functional reprogramming of gut commensals in patients with diabetes and cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1422633","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1422633_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1422633.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1422633.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1422633.csv.gz"}},{"accession":"PRJNA1491285","age_categories":{"adult":64,"elderly":79},"countries":{"US":143},"first_public_year":"2026","gbp_per_sample_median":0.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":143},"intervention_design":"single_arm_before_after","intervention_detail":"Lactulose given to cirrhosis patients, sampled at baseline and 4 weeks","interventions":["drug_therapy"],"n_samples":143,"papers":[],"sample_intervention_arms":{},"sex":{"female":114,"male":29},"title":"Gut microbiota in patients with cirrhosis and portal hypertension receiving lactulose","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1491285","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1491285_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1491285.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1491285.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1491285.csv.gz"}},{"accession":"PRJNA608022","age_categories":{"adult":132,"elderly":7},"countries":{"BE":44,"ES":6,"FR":19,"GB":10,"MX":5,"US":50},"first_public_year":"2020","gbp_per_sample_median":0.29,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":88,"other_disease":36},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":139,"papers":[{"doi":"10.1002/hep.31459","pmcid":"PMC8159727","pmid":"32654263","title":"Intestinal Virome in Patients With Alcoholic Hepatitis."}],"sample_intervention_arms":{},"sex":{"female":37,"male":101},"title":"human viral metagenome Raw sequence reads","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA608022","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA608022_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA608022.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA608022.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA608022.csv.gz"}},{"accession":"PRJNA546034","age_categories":{"child":124},"countries":{},"first_public_year":"2019","gbp_per_sample_median":3.7,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":37,"liver_disease":86},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":124,"papers":[{"doi":"10.1080/19490976.2025.2508951","pmcid":"PMC12101585","pmid":"40396204","title":"Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH."}],"sample_intervention_arms":{},"sex":{"female":46,"male":78},"title":"NAFLD Microbiome","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA546034","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA546034_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA546034.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA546034.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA546034.csv.gz"}},{"accession":"PRJNA1184735","age_categories":{"unknown":122},"countries":{"US":122},"first_public_year":"2024","gbp_per_sample_median":3.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":122},"intervention_design":"none","intervention_detail":"None; cross-sectional observational study, no intervention administered","interventions":[],"n_samples":122,"papers":[{"doi":"10.1016/j.gastha.2025.100695","pmcid":"PMC12197998","pmid":"40574876","title":"Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal butyrate and deoxycholic acid concentrations correlate with mortality in hospitalized patients with liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1184735","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1184735_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1184735.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1184735.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1184735.csv.gz"}},{"accession":"PRJNA1305663","age_categories":{"unknown":122},"countries":{"CN":122},"first_public_year":"2025","gbp_per_sample_median":12.21,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":45,"ibd_or_gi_disease":67},"intervention_design":"single_arm_before_after","intervention_detail":"Kasai portoenterostomy (KPE) surgery, before/after sampling","interventions":["surgery"],"n_samples":122,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic sequences of biliary atresia patients and controls","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1305663","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1305663_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1305663.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1305663.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1305663.csv.gz"}},{"accession":"PRJNA932948","age_categories":{"adult":120},"countries":{"TH":120},"first_public_year":"2023","gbp_per_sample_median":5.18,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":76,"liver_disease":25,"other_cancer":19},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":120,"papers":[{"doi":"10.1038/s41598-023-38307-2","pmcid":"PMC10349051","pmid":"37452065","title":"Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma."},{"doi":"10.1038/s41522-026-00921-z","pmcid":"PMC12966491","pmid":"41605932","title":"Modeling diet-gut microbiome interactions and prebiotic responses in Thai adults."},{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{"female":22,"male":98},"title":"Dysbiosys of the gut microbiota in Thai hepatocellular carcinoma and intrahepatic cholangiocarcinoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA932948","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA932948_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA932948.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA932948.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA932948.csv.gz"}},{"accession":"PRJNA722819","age_categories":{"adult":104},"countries":{"DK":104},"first_public_year":"2021","gbp_per_sample_median":1.73,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":52,"liver_disease":52},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":104,"papers":[{"doi":"10.1128/msystems.00382-21","pmcid":"PMC8525569","pmid":"34665009","title":"A Previously Undescribed Highly Prevalent Phage Identified in a Danish Enteric Virome Catalog."},{"doi":"10.1128/spectrum.01066-24","pmcid":"PMC11792537","pmid":"39745426","title":"Identification and characterization of <i>Faecalibacterium</i> prophages rich in diversity-generating retroelements."},{"doi":"10.1038/s41467-025-58856-6","pmcid":"PMC11986028","pmid":"40210629","title":"Characterization of the phyllosphere virome of fresh vegetables and potential transfer to the human gut."}],"sample_intervention_arms":{},"sex":{},"title":"Gut virome of patients with alcoholic liver disease and healthy individuals","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA722819","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA722819_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA722819.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA722819.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA722819.csv.gz"}},{"accession":"PRJEB18041","age_categories":{"adult":99},"countries":{"RU":99},"first_public_year":"2016","gbp_per_sample_median":1.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":27,"neurological_psychiatric":72},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":99,"papers":[{"doi":"10.1016/j.dib.2017.01.008","pmcid":"PMC5257029","pmid":"28138508","title":"Data on gut metagenomes of the patients with alcoholic dependence syndrome and alcoholic liver cirrhosis."},{"doi":"10.1186/s40168-017-0359-2","pmcid":"PMC5645934","pmid":"29041989","title":"Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease."},{"doi":"10.1186/s13099-022-00482-4","pmcid":"PMC8845349","pmid":"35168645","title":"Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies."}],"sample_intervention_arms":{},"sex":{"female":9,"male":90},"title":"\"Shotgun\" gut metagenomes of the patients with alcohol dependence syndrome and alcoholic liver cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB18041","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB18041_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB18041.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB18041.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB18041.csv.gz"}},{"accession":"PRJEB38483","age_categories":{"unknown":96},"countries":{"GB":96},"first_public_year":"2021","gbp_per_sample_median":2.63,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":96,"papers":[{"doi":"10.1002/imt2.70131","pmcid":"PMC13377410","pmid":"42491347","title":"Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis."}],"sample_intervention_arms":{},"sex":{},"title":"TwinUK cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB38483","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38483_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB38483.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB38483.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38483.csv.gz"}},{"accession":"PRJEB81819","age_categories":{"adult":95},"countries":{"DE":95},"first_public_year":"2024","gbp_per_sample_median":1.45,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":95,"papers":[{"doi":"10.1080/19490976.2025.2487209","pmcid":"PMC12054929","pmid":"40255076","title":"Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation."}],"sample_intervention_arms":{},"sex":{},"title":"microbiota in cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB81819","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB81819_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB81819.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB81819.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB81819.csv.gz"}},{"accession":"PRJNA624763","age_categories":{"adult":27,"elderly":68},"countries":{"CN":95},"first_public_year":"2020","gbp_per_sample_median":11.69,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":3,"cardiometabolic_other":2,"healthy_control":86,"liver_disease":1,"other_infection":2,"type2_diabetes":1},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":95,"papers":[{"doi":"10.1080/19490976.2024.2393756","pmcid":"PMC11364081","pmid":"39197040","title":"Consistent signatures in the human gut microbiome of longevous populations."},{"doi":"10.1371/journal.pone.0305583","pmcid":"PMC11488730","pmid":"39423213","title":"Comprehensive gut microbiota composition and microbial interactions among the three age groups."},{"doi":"10.3389/fnagi.2026.1745455","pmcid":"PMC13021664","pmid":"41907847","title":"Examination of shared gut microbiome signatures in aging and Parkinson's disease."},{"doi":"10.1038/s41467-026-71521-w","pmcid":"PMC13079874","pmid":"41980943","title":"Comprehensive benchmarking of metagenomic binning tools reveals key factors for improved genome recovery."}],"sample_intervention_arms":{},"sex":{"female":56,"male":39},"title":"Shotgun metagenomics of human gut microbiota in China high longevity area","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA624763","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA624763_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA624763.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA624763.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA624763.csv.gz"}},{"accession":"PRJNA622386","age_categories":{"unknown":91},"countries":{"DE":91},"first_public_year":"2020","gbp_per_sample_median":0.28,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":5,"liver_disease":86},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":91,"papers":[{"doi":"10.1053/j.gastro.2020.07.005","pmcid":"PMC8404510","pmid":"32652145","title":"Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease."},{"doi":"10.1038/s41467-025-58856-6","pmcid":"PMC11986028","pmid":"40210629","title":"Characterization of the phyllosphere virome of fresh vegetables and potential transfer to the human gut."}],"sample_intervention_arms":{},"sex":{},"title":"Human feces viral metagenome raw sequence reads associated with NAFLD","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA622386","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA622386_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA622386.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA622386.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA622386.csv.gz"}},{"accession":"PRJNA647523","age_categories":{"adult":90},"countries":{"AU":90},"first_public_year":"2020","gbp_per_sample_median":9.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":90,"papers":[{"doi":"10.1038/s41467-020-20422-7","pmcid":"PMC7794332","pmid":"33420074","title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma."}],"sample_intervention_arms":{},"sex":{},"title":"Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA647523","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA647523_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA647523.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA647523.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA647523.csv.gz"}},{"accession":"PRJNA786875","age_categories":{"adult":82,"elderly":8},"countries":{"BE":90},"first_public_year":"2022","gbp_per_sample_median":0.4,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":1,"other_disease":89},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":90,"papers":[{"doi":"10.1002/hep4.1947","pmcid":"PMC9315129","pmid":"35368152","title":"Intestinal virome in patients with alcohol use disorder and after abstinence."},{"doi":"10.1097/hep.0000000000000238","pmcid":"PMC10192041","pmid":"36631002","title":"Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome."}],"sample_intervention_arms":{},"sex":{"female":28,"male":62},"title":"Intestinal virome in alcohol use disorder and abstinence Raw sequence reads","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA786875","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA786875_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA786875.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA786875.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA786875.csv.gz"}},{"accession":"PRJEB76665","age_categories":{"adult":88},"countries":{"DE":88},"first_public_year":"2025","gbp_per_sample_median":6.32,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":88},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":88,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic analysis of the gut microbiome of advanced liver disease patients","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB76665","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76665_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB76665.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB76665.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76665.csv.gz"}},{"accession":"PRJNA1203401","age_categories":{"adult":78,"elderly":9},"countries":{"HK":87},"first_public_year":"2025","gbp_per_sample_median":12.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":87},"intervention_design":"single_arm_before_after","intervention_detail":"Empagliflozin treatment, baseline to week 52, in MASLD patients","interventions":["drug_therapy"],"n_samples":87,"papers":[{"doi":"10.1111/liv.70023","pmcid":"PMC11827547","pmid":"39950834","title":"Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota predicts treatment response to empagliflozin among MASLD patients without diabetes mellitus","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1203401","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1203401_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1203401.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1203401.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1203401.csv.gz"}},{"accession":"PRJNA373901","age_categories":{"unknown":86},"countries":{"US":86},"first_public_year":"2017","gbp_per_sample_median":6.3,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":50},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":86,"papers":[{"doi":"10.1016/j.cmet.2017.04.001","pmcid":"PMC5502730","pmid":"28467925","title":"Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease."},{"doi":"10.1016/j.jare.2024.06.027","pmcid":"PMC12147647","pmid":"38969095","title":"Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism."},{"doi":"10.1038/s41467-025-57574-3","pmcid":"PMC11882788","pmid":"40044736","title":"Microbiota-derived H<sub>2</sub>S induces c-kit<sup>+</sup> cDC1 autophagic cell death and liver inflammation in metabolic dysfunction-associated steatohepatitis."},{"doi":"10.1152/physiolgenomics.00011.2021","pmcid":"PMC8424563","pmid":"34151600","title":"Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD."},{"doi":"10.1186/s12866-021-02321-z","pmcid":"PMC8485520","pmid":"34592929","title":"MetaGeneBank: a standardized database to study deep sequenced metagenomic data from human fecal specimen."}],"sample_intervention_arms":{},"sex":{},"title":"Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA373901","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA373901_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA373901.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA373901.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA373901.csv.gz"}},{"accession":"PRJNA766067","age_categories":{"adult":84},"countries":{"US":84},"first_public_year":"2021","gbp_per_sample_median":1.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":84},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":84,"papers":[{"doi":"10.1080/19490976.2021.1987781","pmcid":"PMC8583005","pmid":"34747331","title":"The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related Cirrhosis."}],"sample_intervention_arms":{},"sex":{},"title":"The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related Cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA766067","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA766067_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA766067.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA766067.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA766067.csv.gz"}},{"accession":"PRJEB65440","age_categories":{"adult":83},"countries":{"CN":83},"first_public_year":"2024","gbp_per_sample_median":6.34,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":83,"papers":[{"doi":"10.1111/liv.70836","pmcid":"PMC13469701","pmid":"42587419","title":"Disrupted Gut Viral-Bacterial Ecology of Patients With Liver Cirrhosis."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota dysbiosis in Cirrhosis and hepatic encephalopathy","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB65440","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB65440_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB65440.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB65440.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB65440.csv.gz"}},{"accession":"PRJNA1317556","age_categories":{"unknown":80},"countries":{"CN":80},"first_public_year":"2025","gbp_per_sample_median":12.91,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":80},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":80,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiome and metabolome characteristics of the small intestine in patients with ACLF","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1317556","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1317556_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1317556.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1317556.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1317556.csv.gz"}},{"accession":"PRJEB56669","age_categories":{"adult":78},"countries":{},"first_public_year":"2023","gbp_per_sample_median":6.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"liver_disease":78},"intervention_design":"single_arm_before_after","intervention_detail":"Exercise programme for NAFLD patients","interventions":["exercise"],"n_samples":78,"papers":[{"doi":"10.1128/msystems.00224-23","pmcid":"PMC10654067","pmid":"37606372","title":"Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients."}],"sample_intervention_arms":{"exercise":40,"no_intervention":38},"sex":{},"title":"Gut ecological networks reveal associations between bacteria, exercise and clinical profile in non-alcoholic fatty liver disease patients","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB56669","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB56669_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB56669.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB56669.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB56669.csv.gz"}},{"accession":"PRJNA1377628","age_categories":{"adult":76},"countries":{"GB":76},"first_public_year":"2026","gbp_per_sample_median":0.53,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":12,"liver_disease":36},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":76,"papers":[{"doi":"10.64898/2025.12.09.693164","pmcid":null,"pmid":null,"title":"Decoding the microbiome and resistome of advanced chronic liver disease through long-read metagenomics"}],"sample_intervention_arms":{},"sex":{},"title":"Decoding the microbiome and resistome of advanced chronic liver disease through long-read metagenomics","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1377628","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1377628_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1377628.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1377628.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1377628.csv.gz"}},{"accession":"PRJNA613834","age_categories":{"adult":76},"countries":{"US":76},"first_public_year":"2020","gbp_per_sample_median":3.2,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":9,"other_disease":67},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":76,"papers":[{"doi":"10.3389/fphys.2020.00370","pmcid":"PMC7193112","pmid":"32390870","title":"Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder."},{"doi":"10.3390/metabo11110766","pmcid":"PMC8621614","pmid":"34822424","title":"Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease."}],"sample_intervention_arms":{},"sex":{},"title":"Functional Microbial Responses to Alcohol Abstinence in Patients with Alcohol Use Disorder","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA613834","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613834_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA613834.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA613834.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613834.csv.gz"}},{"accession":"PRJNA1195696","age_categories":{"unknown":75},"countries":{},"first_public_year":"2025","gbp_per_sample_median":12.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":75,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Homo sapiens Raw sequence reads","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1195696","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1195696_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1195696.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1195696.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1195696.csv.gz"}},{"accession":"PRJEB14215","age_categories":{"adult":73},"countries":{"ES":32,"IT":41},"first_public_year":"2018","gbp_per_sample_median":3.87,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":73},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":73,"papers":[{"doi":"10.1186/s40168-021-01052-7","pmcid":"PMC8106161","pmid":"33962692","title":"Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome."},{"doi":"10.1016/j.xcrm.2023.101341","pmcid":"PMC10772641","pmid":"38118419","title":"Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity."},{"doi":"10.1002/ctm2.70053","pmcid":"PMC11602751","pmid":"39606796","title":"The gut microbiota-derived metabolite indole-3-propionic acid enhances leptin sensitivity by targeting STAT3 against diet-induced obesity."},{"doi":"10.3389/fmicb.2021.728823","pmcid":"PMC8548776","pmid":"34721326","title":"Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota."},{"doi":"10.12938/bmfh.2024-008","pmcid":"PMC11444864","pmid":"39364122","title":"Lactobacillus acidophilus CICC 6075 attenuates high-fat diet-induced obesity by improving gut microbiota composition and histidine biosynthesis."}],"sample_intervention_arms":{},"sex":{"female":57,"male":16},"title":"The role of the intestinal microflora in non-alcoholic fatty liver disease (NAFLD) (FP7)","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB14215","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB14215_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB14215.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB14215.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB14215.csv.gz"}},{"accession":"PRJNA1307628","age_categories":{"adult":1,"unknown":72},"countries":{"GB":73},"first_public_year":"2026","gbp_per_sample_median":11.21,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":73},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":73,"papers":[{"doi":"10.1038/s41564-025-02223-0","pmcid":"PMC12768972","pmid":"41461922","title":"Microbial collagenase activity is linked to oral-gut translocation in advanced chronic liver disease."}],"sample_intervention_arms":{},"sex":{"female":42,"male":27},"title":"Microbial oral-gut translocation in advanced chronic liver disease is linked to exacerbation of intestinal barrier dysfunction and hepatic fibrosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1307628","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1307628_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1307628.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1307628.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1307628.csv.gz"}},{"accession":"PRJEB51056","age_categories":{"adult":68},"countries":{"CH":68},"first_public_year":"2022","gbp_per_sample_median":1.98,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":68,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"COMALF","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB51056","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB51056_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB51056.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB51056.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB51056.csv.gz"}},{"accession":"PRJNA517801","age_categories":{"unknown":68},"countries":{"JP":68},"first_public_year":"2019","gbp_per_sample_median":0.52,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":24,"liver_disease":21},"intervention_design":"none","intervention_detail":"Mouse study of YB328 strain; human fecal samples are liver disease vs healthy controls, no human intervention described","interventions":[],"n_samples":68,"papers":[{"doi":"10.1038/s41586-025-09249-8","pmcid":"PMC12390848","pmid":"40659786","title":"Microbiota-driven antitumour immunity mediated by dendritic cell migration."}],"sample_intervention_arms":{},"sex":{},"title":"WGS_Liver_disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA517801","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA517801_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA517801.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA517801.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA517801.csv.gz"}},{"accession":"PRJNA1144402","age_categories":{"unknown":67},"countries":{"US":67},"first_public_year":"2026","gbp_per_sample_median":10.16,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":32,"liver_disease":35},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":67,"papers":[{"doi":"10.3389/fmicb.2026.1851892","pmcid":"PMC13393096","pmid":"42495136","title":"Chronic hepatitis D infection is associated with distinguishing microbial and functional features in the gut microbiome."}],"sample_intervention_arms":{},"sex":{},"title":"Patients Infected with the Hepatitis D Virus have a Unique Gut Microbiome with Distinguishing Microbial and Functional Features","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1144402","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1144402_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1144402.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1144402.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1144402.csv.gz"}},{"accession":"PRJEB120968","age_categories":{"adult":66},"countries":{"SE":66},"first_public_year":"2026","gbp_per_sample_median":6.34,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":66,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome profiles associated with simple liver steatosis in MASLD: Swedish cohort.","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB120968","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB120968_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB120968.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB120968.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB120968.csv.gz"}},{"accession":"PRJEB76307","age_categories":{"adult":66},"countries":{"CA":66},"first_public_year":"2024","gbp_per_sample_median":18.64,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":66},"intervention_design":"crossover","intervention_detail":"Camu-camu polyphenol extract capsules 1.5g/day, 12 weeks, vs placebo","interventions":["dietary_supplement"],"n_samples":66,"papers":[{"doi":"10.1016/j.xcrm.2024.101682","pmcid":"PMC11384942","pmid":"39168095","title":"Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial."}],"sample_intervention_arms":{},"sex":{},"title":"Camu-camu decreases steatosis and markers of liver injury (Shotgun sequencing).","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB76307","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76307_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB76307.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB76307.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76307.csv.gz"}},{"accession":"PRJNA1438274","age_categories":{"adult":34,"elderly":32},"countries":{"US":66},"first_public_year":"2026","gbp_per_sample_median":39.41,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":35,"healthy_control":12,"liver_disease":19},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":66,"papers":[{"doi":"10.1016/j.isci.2026.117312","pmcid":"PMC13524746","pmid":"42668680","title":"Proximity-ligation metagenomics reveals differential plasmid and chromosomal antimicrobial resistance gene carriage in disrupted gut ecosystems."}],"sample_intervention_arms":{},"sex":{"female":31,"male":22},"title":"Proximity-ligation metagenomics of rCDI and Cirrhosis Patients","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1438274","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1438274_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1438274.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1438274.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1438274.csv.gz"}},{"accession":"PRJNA914785","age_categories":{"child":62},"countries":{"CN":62},"first_public_year":"2023","gbp_per_sample_median":8.29,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":62,"papers":[{"doi":"10.1128/spectrum.01006-23","pmcid":"PMC10846053","pmid":"38189294","title":"Role of intestinal flora in the development of nonalcoholic fatty liver disease in children."},{"doi":"10.1080/19490976.2025.2508951","pmcid":"PMC12101585","pmid":"40396204","title":"Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH."}],"sample_intervention_arms":{},"sex":{},"title":"gut microbiota of Children NAFLD Raw sequence reads","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA914785","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA914785_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA914785.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA914785.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA914785.csv.gz"}},{"accession":"PRJNA941376","age_categories":{"unknown":61},"countries":{"CN":61},"first_public_year":"2023","gbp_per_sample_median":11.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":61},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":61,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiological characteristics of the intestinal tract in lean non-alcoholic fatty liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA941376","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA941376_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA941376.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA941376.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA941376.csv.gz"}},{"accession":"PRJNA890867","age_categories":{"adolescent":54,"child":4},"countries":{"CN":58},"first_public_year":"2024","gbp_per_sample_median":4.87,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":31,"liver_disease":27},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":58,"papers":[{"doi":"10.1038/s41598-022-25140-2","pmcid":"PMC9767906","pmid":"36539432","title":"The relationship of Megamonas species with nonalcoholic fatty liver disease in children and adolescents revealed by metagenomics of gut microbiota."},{"doi":"10.1080/19490976.2025.2508951","pmcid":"PMC12101585","pmid":"40396204","title":"Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH."}],"sample_intervention_arms":{},"sex":{"female":16,"male":42},"title":"metagenomic analysi of NAFLD children and adolescents","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA890867","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA890867_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA890867.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA890867.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA890867.csv.gz"}},{"accession":"PRJNA1372073","age_categories":{"unknown":57},"countries":{"CN":57},"first_public_year":"2026","gbp_per_sample_median":13.59,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":5,"liver_disease":52},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":57,"papers":[{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{},"title":"Hepatocellular Carcinoma Cohort Metagenomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1372073","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372073_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1372073.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1372073.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372073.csv.gz"}},{"accession":"PRJNA1308792","age_categories":{"adult":56},"countries":{"CN":56},"first_public_year":"2025","gbp_per_sample_median":11.37,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":56},"intervention_design":"observational_with_procedure","intervention_detail":"FMT from healthy donors in ALD mouse model; human microbiome analysis","interventions":[],"n_samples":56,"papers":[{"doi":"10.3389/fmicb.2026.1744446","pmcid":"PMC13013527","pmid":"41889649","title":"Fecal microbiota transplantation ameliorates alcohol-associated liver disease through coordinated restoration of short-chain fatty acid and <i>α</i>-linolenic acid signaling."}],"sample_intervention_arms":{},"sex":{},"title":"Microbial diversity in patients with alcoholic liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1308792","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1308792_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1308792.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1308792.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1308792.csv.gz"}},{"accession":"PRJNA1234627","age_categories":{"adult":55},"countries":{"CN":55},"first_public_year":"2025","gbp_per_sample_median":6.71,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":55},"intervention_design":"single_arm_before_after","intervention_detail":"","interventions":[],"n_samples":55,"papers":[{"doi":"10.1016/j.cmet.2025.10.017","pmcid":null,"pmid":"41270737","title":"Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD."}],"sample_intervention_arms":{},"sex":{},"title":"Resistant starch intervention in patients with MASLD","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1234627","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1234627_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1234627.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1234627.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1234627.csv.gz"}},{"accession":"PRJNA1294521","age_categories":{"adult":40,"elderly":15},"countries":{"US":55},"first_public_year":"2025","gbp_per_sample_median":0.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":55},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":55,"papers":[{"doi":"10.1080/19490976.2025.2608437","pmcid":"PMC12773562","pmid":"41481156","title":"Bile salt hydrolase activity as a rational target for MASLD therapy."}],"sample_intervention_arms":{},"sex":{"female":25,"male":30},"title":"16S sequencing of MASLD patient fecal samples","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1294521","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1294521_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1294521.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1294521.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1294521.csv.gz"}},{"accession":"PRJNA1104421","age_categories":{"adult":54},"countries":{"FR":54},"first_public_year":"2024","gbp_per_sample_median":1.85,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"liver_disease":54},"intervention_design":"single_arm_before_after","intervention_detail":"7-day corticosteroid (prednisolone) therapy in severe alcoholic hepatitis","interventions":["drug_therapy"],"n_samples":54,"papers":[{"doi":"10.1080/19490976.2024.2382767","pmcid":"PMC11290774","pmid":"39078043","title":"Serum bile acids profiles are altered without change of the gut microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis."}],"sample_intervention_arms":{"drug_therapy":27,"no_intervention":27},"sex":{},"title":"Serum Bile Acids profiles are altered without change of the Gut Microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1104421","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1104421_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1104421.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1104421.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1104421.csv.gz"}},{"accession":"PRJNA1111312","age_categories":{"adult":21,"elderly":30},"countries":{"FR":51},"first_public_year":"2024","gbp_per_sample_median":1.56,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":51},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":51,"papers":[{"doi":"10.1016/j.gastha.2024.07.020","pmcid":"PMC11785905","pmid":"39895875","title":"Shotgun Metagenomics Reveals Bacteroides stercoris as a Fecal Biomarker Depleted in Late-Stage Hepatocellular Carcinoma."}],"sample_intervention_arms":{},"sex":{"female":6,"male":45},"title":"Shotgun metagenomics reveals Bacteroides stercoris as a fecal biomarker depleted in late-stage hepatocellular carcinoma","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1111312","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1111312_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1111312.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1111312.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1111312.csv.gz"}},{"accession":"PRJNA420817","age_categories":{"adult":48},"countries":{},"first_public_year":"2018","gbp_per_sample_median":5.23,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"obesity":48},"intervention_design":"single_arm_before_after","intervention_detail":"Isocaloric low-carbohydrate diet, short-term, in obese NAFLD subjects","interventions":["diet_intervention"],"n_samples":48,"papers":[{"doi":"10.1016/j.cmet.2018.01.005","pmcid":"PMC6706084","pmid":"29456073","title":"An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans."},{"doi":"10.3390/ijms22073652","pmcid":"PMC8038126","pmid":"33915727","title":"Diet-Related Alterations of Gut Bile Salt Hydrolases Determined Using a Metagenomic Analysis of the Human Microbiome."},{"doi":"10.1152/physiolgenomics.00011.2021","pmcid":"PMC8424563","pmid":"34151600","title":"Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD."},{"doi":"10.1186/s40168-023-01604-z","pmcid":"PMC10408196","pmid":"37553697","title":"Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions."},{"doi":"10.1128/msystems.00817-24","pmcid":"PMC11748489","pmid":"39688414","title":"Systematic identification of secondary bile acid production genes in global microbiome."}],"sample_intervention_arms":{},"sex":{},"title":"gut microbiome in subjects with NAFLD Metagenome","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA420817","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA420817_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA420817.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA420817.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA420817.csv.gz"}},{"accession":"PRJNA1194298","age_categories":{"adolescent":46},"countries":{},"first_public_year":"2026","gbp_per_sample_median":12.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":17},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":46,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Homo sapiens Raw sequence reads","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1194298","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1194298_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1194298.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1194298.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1194298.csv.gz"}},{"accession":"PRJEB76662","age_categories":{"unknown":40},"countries":{"DK":40},"first_public_year":"2024","gbp_per_sample_median":7.4,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Acute alcohol intake challenge in ALD/NAFLD/healthy subjects","interventions":["other_intervention"],"n_samples":40,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic analysis of the gut microbiome in the AlcoChallenge cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB76662","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76662_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB76662.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB76662.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB76662.csv.gz"}},{"accession":"PRJNA480711","age_categories":{"adolescent":22,"adult":2,"child":16},"countries":{"US":40},"first_public_year":"2019","gbp_per_sample_median":1.76,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":20,"healthy_control":20},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":40,"papers":[{"doi":"10.3389/fmicb.2021.713234","pmcid":"PMC8406633","pmid":"34475864","title":"Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children."},{"doi":"10.3389/fmicb.2023.1257903","pmcid":"PMC10797006","pmid":"38249477","title":"The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease."},{"doi":"10.1080/19490976.2025.2508951","pmcid":"PMC12101585","pmid":"40396204","title":"Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH."}],"sample_intervention_arms":{},"sex":{"female":16,"male":24},"title":"Gut and oral metagenomic signature of fatty liver disease in a pediatric population","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA480711","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA480711_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA480711.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA480711.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA480711.csv.gz"}},{"accession":"PRJNA730640","age_categories":{"unknown":40},"countries":{"CN":40},"first_public_year":"2021","gbp_per_sample_median":6.35,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":10,"liver_disease":30},"intervention_design":"observational_with_procedure","intervention_detail":"Liver transplantation and prior Kasai surgery in biliary atresia","interventions":["surgery"],"n_samples":40,"papers":[{"doi":"10.3389/fphys.2021.704313","pmcid":"PMC8273867","pmid":"34262484","title":"Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver Transplantation."},{"doi":"10.3389/fmed.2021.704328","pmcid":"PMC8502819","pmid":"34646837","title":"Effects of Previous Kasai Surgery on Gut Microbiota and Bile Acid in Biliary Atresia With End-Stage Liver Disease."},{"doi":"10.1128/spectrum.00665-23","pmcid":"PMC10269646","pmid":"37191543","title":"Exploring Molecular Interactions between Human Milk Hormone Insulin and Bifidobacteria."},{"doi":"10.1128/msystems.00929-24","pmcid":"PMC11494892","pmid":"39287373","title":"Exploring the vitamin biosynthesis landscape of the human gut microbiota."}],"sample_intervention_arms":{"no_intervention":10,"surgery":14},"sex":{},"title":"The composition of gut microbiota in biliary atresia","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA730640","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA730640_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA730640.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA730640.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA730640.csv.gz"}},{"accession":"PRJEB27662","age_categories":{"adult":38},"countries":{"KR":38},"first_public_year":"2020","gbp_per_sample_median":1.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":38,"papers":[{"doi":"10.1038/s41467-020-18754-5","pmcid":"PMC7536225","pmid":"33020474","title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD."},{"doi":"10.1016/j.csbj.2021.10.032","pmcid":"PMC8591343","pmid":"34849196","title":"Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease."},{"doi":"10.1080/19490976.2022.2078612","pmcid":"PMC9154801","pmid":"35634707","title":"Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic <i>de novo</i> lipogenesis."},{"doi":"10.3390/ijms25042183","pmcid":"PMC10889285","pmid":"38396863","title":"Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Entero"}],"sample_intervention_arms":{},"sex":{},"title":"Human gut microbiome in Korean NAFLD cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB27662","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB27662_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB27662.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB27662.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB27662.csv.gz"}},{"accession":"PRJEB120969","age_categories":{"adult":36},"countries":{"AT":36},"first_public_year":"2026","gbp_per_sample_median":5.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":36,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome profiles associated with simple liver steatosis in MASLD: Austrian cohort.","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB120969","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB120969_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB120969.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB120969.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB120969.csv.gz"}},{"accession":"PRJNA1416570","age_categories":{"adolescent":2,"adult":27,"child":1,"elderly":6},"countries":{"CN":36},"first_public_year":"2026","gbp_per_sample_median":10.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":36},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":36,"papers":[{"doi":"10.1371/journal.pone.0343817","pmcid":"PMC12944773","pmid":"41746975","title":"Effects of tacrolimus treatment on the gut microbiota and metabolites in liver transplant recipients."}],"sample_intervention_arms":{},"sex":{"female":3,"male":33},"title":"gut microbiota and metabolites","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1416570","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1416570_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1416570.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1416570.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1416570.csv.gz"}},{"accession":"PRJNA328258","age_categories":{"adolescent":22,"child":14},"countries":{"US":36},"first_public_year":"2022","gbp_per_sample_median":3.68,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":17,"obesity":19},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":36,"papers":[{"doi":"10.1210/clinem/dgaa382","pmcid":"PMC7458486","pmid":"32561908","title":"Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth."},{"doi":"10.1002/hep4.1944","pmcid":"PMC9315112","pmid":"35344283","title":"Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth."},{"doi":"10.3389/fmicb.2023.1257903","pmcid":"PMC10797006","pmid":"38249477","title":"The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease."},{"doi":"10.1186/s12866-024-03425-y","pmcid":"PMC11264842","pmid":"39030520","title":"Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity."},{"doi":"10.1080/19490976.2025.2508951","pmcid":"PMC12101585","pmid":"40396204","title":"Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH."}],"sample_intervention_arms":{},"sex":{"female":18,"male":18},"title":"feces metagenome Metagenome","trial_population_condition":"obesity","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA328258","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA328258_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA328258.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA328258.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA328258.csv.gz"}},{"accession":"PRJNA1172418","age_categories":{"adult":30},"countries":{"FR":30},"first_public_year":"2025","gbp_per_sample_median":3.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":30},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":30,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Development of a model predicting 90-day survival in severe alcohol-related hepatitis using a retrospective cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1172418","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1172418_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1172418.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1172418.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1172418.csv.gz"}},{"accession":"PRJNA1334189","age_categories":{"unknown":25},"countries":{"CN":25},"first_public_year":"2025","gbp_per_sample_median":6.71,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":22,"other_infection":1},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":25,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"The gut microbiome of human liver diseases","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1334189","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1334189_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1334189.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1334189.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1334189.csv.gz"}},{"accession":"PRJNA970820","age_categories":{"adult":12,"elderly":9},"countries":{"US":21},"first_public_year":"2023","gbp_per_sample_median":3.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":21},"intervention_design":"observational_with_procedure","intervention_detail":"Liver transplantation cohort, stool sampled post-transplant","interventions":["surgery"],"n_samples":21,"papers":[{"doi":"10.1038/s41597-024-04153-8","pmcid":"PMC11717916","pmid":"39788961","title":"Deep sequencing-derived Metagenome Assembled Genomes from the gut microbiome of liver transplant patients."}],"sample_intervention_arms":{},"sex":{"female":10,"male":11},"title":"human gut metagenome Genome sequencing and assembly","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA970820","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA970820_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA970820.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA970820.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA970820.csv.gz"}},{"accession":"PRJEB75921","age_categories":{"adult":20},"countries":{"CN":20},"first_public_year":"2024","gbp_per_sample_median":14.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":20,"papers":[{"doi":"10.1099/acmi.0.000859.v6","pmcid":"PMC12369552","pmid":"40852466","title":"Potential role of gut bacteria in the development of hepatocellular carcinoma."}],"sample_intervention_arms":{},"sex":{},"title":"The potential role of gut microbiota in the occurrence and development of liver cancer","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB75921","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB75921_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB75921.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB75921.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB75921.csv.gz"}},{"accession":"PRJDB5180","age_categories":{"adult":9,"elderly":7},"countries":{"JP":16},"first_public_year":"2017","gbp_per_sample_median":0.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":16},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":16,"papers":[{"doi":"10.3389/fmicb.2017.00685","pmcid":"PMC5397476","pmid":"28473817","title":"Comprehensive Diagnosis of Bacterial Infection Associated with Acute Cholecystitis Using Metagenomic Approach."}],"sample_intervention_arms":{},"sex":{"female":9,"male":7},"title":"A metagenomic approach for acute cholecystitis patients enables pathogen detection and rapid diagnostics","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB5180","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB5180_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB5180.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB5180.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB5180.csv.gz"}},{"accession":"PRJNA1297975","age_categories":{"unknown":16},"countries":{"CN":16},"first_public_year":"2025","gbp_per_sample_median":7.1,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Mediterranean diet feeding intervention in mouse MASLD model","interventions":["diet_intervention"],"n_samples":16,"papers":[{"doi":"10.3389/fnut.2025.1644014","pmcid":"PMC12378279","pmid":"40873449","title":"Multi-omics integration reveals the impact of mediterranean diet on hepatic metabolism and gut microbiota in mice with metabolic dysfunction-associated steatotic liver disease."}],"sample_intervention_arms":{},"sex":{},"title":"Mediterranean diet intervention for intestinal microecology in metabolic-related fatty liver disease","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1297975","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1297975_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1297975.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1297975.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1297975.csv.gz"}},{"accession":"PRJDB10484","age_categories":{"unknown":12},"countries":{"JP":12},"first_public_year":"2022","gbp_per_sample_median":14.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":12},"intervention_design":"observational_with_procedure","intervention_detail":"Rifaximin (nonabsorbable antibiotic) administration in HE patients","interventions":["antibiotic"],"n_samples":12,"papers":[{"doi":"10.1002/hep4.1954","pmcid":"PMC9315133","pmid":"35429147","title":"Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbial species responsible for hyperammonemia-related urease activity in hepatic encephalopathy patients","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB10484","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB10484_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB10484.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB10484.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB10484.csv.gz"}},{"accession":"PRJNA1167913","age_categories":{"adult":12},"countries":{"CN":12},"first_public_year":"2024","gbp_per_sample_median":10.02,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":6,"other_infection":6},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":12,"papers":[{"doi":"10.1080/07853890.2025.2474730","pmcid":"PMC11892071","pmid":"40052450","title":"Decreased intestinal abundance of <i>Akkermansia muciniphila</i> is associated with metabolic disorders among people living with HIV."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic sequencing of human fecal samples from NAFLD and non-NAFLD patients infected with HIV","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1167913","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1167913_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1167913.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1167913.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1167913.csv.gz"}},{"accession":"PRJNA1468588","age_categories":{"adult":4},"countries":{"US":4},"first_public_year":"2026","gbp_per_sample_median":13.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":4},"intervention_design":"single_arm_before_after","intervention_detail":"Vancomycin treatment, longitudinal case study","interventions":["antibiotic"],"n_samples":4,"papers":[{"doi":"10.1093/ecco-jcc/jjag099","pmcid":null,"pmid":"42490468","title":"Rapid resolution of colon inflammation and microbiome remodeling with vancomycin therapy in a patient with primary sclerosing cholangitis."}],"sample_intervention_arms":{"antibiotic":3,"no_intervention":1},"sex":{},"title":"Gut microbiome dynamics in a primary sclerosing cholangitis patient treated with vancomycin","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1468588","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1468588_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1468588.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1468588.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1468588.csv.gz"}},{"accession":"PRJNA771999","age_categories":{"adult":2},"countries":{"US":2},"first_public_year":"2021","gbp_per_sample_median":5.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":2,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Virulence Factors in Cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA771999","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA771999_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA771999.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA771999.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA771999.csv.gz"}},{"accession":"PRJNA678582","age_categories":{"adult":1},"countries":{"US":1},"first_public_year":"2020","gbp_per_sample_median":3.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Rifaximin 8-week open-label trial in compensated cirrhosis, pre/post ARG comparison","interventions":["antibiotic"],"n_samples":1,"papers":[{"doi":"10.1053/j.gastro.2021.04.013","pmcid":"PMC9069394","pmid":"33857456","title":"Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis."}],"sample_intervention_arms":{},"sex":{},"title":"Cirrhosis metagenomics","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA678582","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678582_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA678582.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA678582.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678582.csv.gz"}}],"release":"R2026.25"}